Closing the gaps in recruitment and retention in cancer trials: sufficient evidence but poor implementation.
作者信息
Pellizzari Giulia
机构信息
CRUK & UCL Cancer Trials Centre, Cancer Institute, University College London, London, UK.
出版信息
BMJ Oncol. 2023 Nov 20;2(1):e000195. doi: 10.1136/bmjonc-2023-000195. eCollection 2023.
Abstract
摘要
相似文献
1
Closing the gaps in recruitment and retention in cancer trials: sufficient evidence but poor implementation.
BMJ Oncol. 2023 Nov 20;2(1):e000195. doi: 10.1136/bmjonc-2023-000195. eCollection 2023.
2
Recruitment and retention challenges and strategies in randomized controlled trials of psychosocial interventions for children with cancer and their parents: a collective case study.
Eur J Pediatr. 2023 Oct;182(10):4683-4706. doi: 10.1007/s00431-023-05139-1. Epub 2023 Aug 10.
3
A multilevel framework for recruitment and retention in implementation trials: An illustrative example.
Clin Trials. 2025 Jun;22(3):325-341. doi: 10.1177/17407745241307948. Epub 2025 Jan 10.
4
Undertaking Studies Within A Trial to evaluate recruitment and retention strategies for randomised controlled trials: lessons learnt from the PROMETHEUS research programme.
Health Technol Assess. 2024 Jan;28(2):1-114. doi: 10.3310/HTQW3107.
5
Closing the gap in implementation of HIV clinical guidelines in a low resource setting using electronic medical records.
BMC Health Serv Res. 2020 Aug 26;20(1):804. doi: 10.1186/s12913-020-05613-8.
6
Access and Representation: A Narrative Review of the Disparities in Access to Clinical Trials and Precision Oncology in Black men with Prostate Cancer.
Urology. 2022 May;163:90-98. doi: 10.1016/j.urology.2021.09.004. Epub 2021 Sep 25.
7
Behavioural approaches to recruitment and retention in clinical trials: a systematic mapping review.
BMJ Open. 2022 Mar 9;12(3):e054854. doi: 10.1136/bmjopen-2021-054854.
8
Recruitment and Retention Strategies for Historically Marginalized Populations in Colorectal Cancer Trials: A Cross-Sectional Analysis Using Systematic Review Methods.
J Gastrointest Cancer. 2024 Nov 26;56(1):24. doi: 10.1007/s12029-024-01146-z.
9
Retention rates and reasons for non-retention in exercise oncology trials in the post-treatment phase-a systematic review.
J Cancer Surviv. 2024 Apr 3. doi: 10.1007/s11764-024-01569-4.
10
Global Oncology Nursing Recruitment and Retention: A SWOT Analysis.
Semin Oncol Nurs. 2023 Feb;39(1):151361. doi: 10.1016/j.soncn.2022.151361. Epub 2023 Jan 7.
本文引用的文献
1
It Is Time to Close the Gap in Cancer Care.
JCO Glob Oncol. 2023 Jan;9:e2200429. doi: 10.1200/GO.22.00429.
2
Racial and Ethnic Disparities in Cancer Care During the COVID-19 Pandemic.
JAMA Netw Open. 2022 Jul 1;5(7):e2222009. doi: 10.1001/jamanetworkopen.2022.22009.
3
Barriers to patient enrolment in phase III cancer clinical trials: interviews with clinicians and pharmaceutical industry representatives.
BMJ Open. 2022 Feb 17;12(2):e055165. doi: 10.1136/bmjopen-2021-055165.
4
Patient and public involvement for ethnic minority research: an urgent need for improvement.
J R Soc Med. 2021 Jul;114(7):347-350. doi: 10.1177/0141076821994274. Epub 2021 Feb 24.
5
Sociodemographic diversity in cancer clinical trials: New findings on the effect of race and ethnicity.
Contemp Clin Trials Commun. 2021 Jan 20;21:100718. doi: 10.1016/j.conctc.2021.100718. eCollection 2021 Mar.
6
Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process.
Trials. 2020 Aug 1;21(1):694. doi: 10.1186/s13063-020-04613-7.
7
Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis.
BMJ. 2018 Nov 28;363:k4738. doi: 10.1136/bmj.k4738.
8
Immuno-oncology Clinical Trial Design: Limitations, Challenges, and Opportunities.
Clin Cancer Res. 2017 Sep 1;23(17):4992-5002. doi: 10.1158/1078-0432.CCR-16-3066.
9
Participation in cancer clinical trials: why are patients not participating?
Med Decis Making. 2014 Jan;34(1):116-26. doi: 10.1177/0272989X13497264. Epub 2013 Jul 29.
Zotero 插件